CN104688742B - Preparation containing cefobutazine sodium - Google Patents

Preparation containing cefobutazine sodium Download PDF

Info

Publication number
CN104688742B
CN104688742B CN201510124363.0A CN201510124363A CN104688742B CN 104688742 B CN104688742 B CN 104688742B CN 201510124363 A CN201510124363 A CN 201510124363A CN 104688742 B CN104688742 B CN 104688742B
Authority
CN
China
Prior art keywords
parts
cefobutazine sodium
sodium
aerosol
cefobutazine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201510124363.0A
Other languages
Chinese (zh)
Other versions
CN104688742A (en
Inventor
牛敬媛
张彬
王帅
赵杉
闫晓晓
王海涛
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xinxiang Medical University
Original Assignee
Xinxiang Medical University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xinxiang Medical University filed Critical Xinxiang Medical University
Priority to CN201510124363.0A priority Critical patent/CN104688742B/en
Publication of CN104688742A publication Critical patent/CN104688742A/en
Application granted granted Critical
Publication of CN104688742B publication Critical patent/CN104688742B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The application relates to a kind of cefobutazine sodium aerosol, and it includes by weight: cefobutazine sodium 5 parts, ethanol 450 parts, polysorbate 40 8 parts, lauryl alcohol 5 parts, F12550 parts.

Description

Preparation containing cefobutazine sodium
Technical field
The application relates to a kind of aerosol, specifically, is the aerosol containing cefobutazine sodium.
Background technology
Cefobutazine sodium, calls Ceftezole Sodium, and its chemical name is: (6R, 7R)-3-[(1,3,4-thiadiazoles-2-base) sulfur generation Methyl]-8-oxo-7-[2-(1H-TETRAZOLE-1-base) acetylamino]-5-thia-1-azabicyclo [4.2.0] oct-2-ene-2 first Acid sodium, English another name: 5-Thia-1-azabicyclo [4,2,0] oct-2-ene-2-carboxylic sodium or sodium(6S,7R)-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-3-[(1,3,4-thiadiazol-2- ylsulf anyl)methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate.This product is White to light yellow crystalline powder, odorless, have draw moist.Cefobutazine sodium is semisynthetic cephalosporins derivatives, and it is made It is by suppressing the synthesis of bacteria cell wall to play antibacterial activity by mechanism.Cefobutazine sodium has antibacterial work to following antibacterial Property: aerobic gram positive bacteria: staphylococcus aureus, streptococcus pneumoniae, micrococcus scarlatinae;Aerobic gram-negative bacteria: Escherichia coli, klebsiella pneumoniae, Bacillus proteus.Indication is septicemia, pneumonia, bronchitis, bronchiectasis (sense During dye), the secondary infection of chronic respiratory system diseases, pulmonary abscess, peritonitis, pyelonephritis, cystitis, urethritis.
Cefobutazine sodium has good curative effect in terms for the treatment of respiratory system infection.Report such as Jiang Ying etc., cefobutazine sodium Treatment pneumonia of newborn 40 example observation of curative effect, it is short that the heat of result use cefobutazine sodium moves back the time, and pulmonary's sound regression time is fast And the hospital stays is short, total effective rate is 90.00%, is better than using Cefazolin sodium, does not finds obvious adverse reaction.Prior art In be mostly cefobutazine sodium to be prepared as injection or freeze-dried powder is used for intravenous administration, there is administration pain, system The shortcomings such as agent transport inconvenience.Especially for juvenile and the young children for the treatment of respiratory system infection, owing to fearing pain, vein Drug administration by injection has difficulties, and is badly in need of developing a kind of easy to use, new formulation of easy administration.The present invention is contemplated to solve this Individual technical problem, is the most not yet disclosed the correlational study about cefobutazine sodium aerosol.
Summary of the invention
The present invention is to solve that existing cefobutazine sodium is administered the shortcoming of inconvenience, invented cefobutazine sodium aerosol.
The present invention uses the specific adjuvant of aerosol and consumption, and the cefobutazine sodium aerosol spray prepared is good, draws Moist good.
The invention provides a kind of ceftezole preparation of sodium, wherein active component is cefobutazine sodium.
The invention provides a kind of ceftezole preparation of sodium, it is cefobutazine sodium aerosol.
The invention provides a kind of cefobutazine sodium aerosol, it includes by weight,
Cefobutazine sodium: 5 parts
Solvent: 450 parts
Polysorbate 40: 8 parts
Lauryl alcohol: 5 parts
Propellant: 550 parts.
The invention provides a kind of cefobutazine sodium aerosol, wherein solvent is ethanol, and propellant is F12(dichlorodifluoro first Alkane).
The present invention uses polysorbate 40 and lauryl alcohol as solubilizing agent and suspending agent especially, can not only improve aerosol Stability, additionally it is possible to avoid cefobutazine sodium to condense, increase curative effect.
The preparation method of cefobutazine sodium aerosol of the present invention, it is characterised in that comprise the following steps:
(1) dissolve cefobutazine sodium with ethanol, obtain clear and bright uniform solution;
(2) weigh polysorbate 40 and the lauryl alcohol of recipe quantity respectively, add in above-mentioned solution, wiring solution-forming system;
(3) loading in container by step (2) gained solution, dress valve is tightened, and is pressed into propellant F12, shake up, obtain aerosol Agent.
The all measurement units of the present invention are weight.
The concentration of alcohol that the present invention uses is 95%-100%.
Detailed description of the invention
The present invention is explained further below in conjunction with embodiment, but the present invention is not done any type of limit by embodiment Fixed.
Embodiment 1
Cefobutazine sodium: 5 parts
Ethanol: 450 parts
Polysorbate 40: 8 parts
Lauryl alcohol: 5 parts
F12: 550 parts.
Preparation method:
(1) dissolve cefobutazine sodium with ethanol, obtain clear and bright uniform solution;
(2) weigh polysorbate 40 and the lauryl alcohol of recipe quantity respectively, add in above-mentioned solution, wiring solution-forming system;
(3) loading in container by step (2) gained solution, dress valve is tightened, and is pressed into propellant F12, shake up, obtain aerosol Agent.
Comparative example 1
Cefobutazine sodium: 5 parts
Glycerol: 450 parts
Polysorbate 40: 8 parts
Lauryl alcohol: 5 parts
F12: 550 parts.
Preparation method is with embodiment 1.
Comparative example 2
Cefobutazine sodium: 5 parts
Ethanol: 450 parts
Lauryl alcohol: 5 parts
F12: 550 parts.
Preparation method is with embodiment 1.
Comparative example 3
Cefobutazine sodium: 5 parts
Ethanol: 450 parts
Polysorbate 40: 8 parts
F12: 550 parts.Preparation method is with embodiment 1.
Comparative example 4
Cefobutazine sodium: 5 parts
Ethanol: 450 parts
F12: 550 parts.Preparation method is with embodiment 1.
Comparative example 5
Cefobutazine sodium: 10 parts
Ethanol: 300 parts
Polysorbate 40: 5 parts
Lauryl alcohol: 10 parts
F12: 400 parts.
Preparation method is with embodiment 1.
Comparative example 6
Cefobutazine sodium: 5 parts
Ethanol: 450 parts
Sorbitan Trioleate: 8 parts
F12: 550 parts.
Preparation method is with embodiment 1.
Comparative example 7
Cefobutazine sodium: 5 parts
Ethanol: 450 parts
Oleyl alcohol: 8 parts
Sorbitan Trioleate: 5 parts
F12: 550 parts.
Preparation method is with embodiment 1.
Comparative example 8
Cefobutazine sodium: 5 parts
Ethanol: 450 parts
Polysorbate 40: 8 parts
Lauryl alcohol: 5 parts
F11: 550 parts.
Preparation method is with embodiment 1.
Aerosol adjuvant in embodiment 1 prescription or consumption are modified by above-mentioned comparative example 1-8, specifically become Change situation is as follows:
Embodiment 2 cefobutazine sodium aerosol accelerated test
Accelerated test: take cefobutazine sodium aerosol embodiment 1 of the present invention and comparative example's 1-8 sample, be placed in DHS- In 100 climatic chambers (Beijing refined scholar woods experimental facilities company limited), regulation temperature is 40 DEG C, and relative humidity is 75%, in 1,2,3,6 each moons respectively sampled once, detection ceftezole sodium content (percentage by weight), the results are shown in Table 1.
Table 1 cefobutazine sodium aerosol accelerated test result
Table 1 accelerated test result
From table 1, the stability of embodiment 1 aerosol is best, either changes aerosol adjuvant or consumption, all can Significantly reduce the stability of cefobutazine sodium aerosol.
Embodiment 3 cefobutazine sodium aerosol room temperature reserved sample observing result
Carry out aerosol observation analysis directly perceived according to Chinese Pharmacopoeia version two in 2000, the results are shown in Table 2.
Table 2
According to table 2, the aerosol that ethanol solution prepares is the most stable, and with polysorbate 40 and lauryl alcohol as cosolvent The aerosol solution each side sense organ being made into is best.
Embodiment 4 Clinical practice effect
Select patients with pneumonia 33 example repeatedly failed to respond to any medical treatment through existing Therapeutic Method, carry out clinical point according to severity extent Level, including slight, moderate and severe patient, is respectively adopted cefobutazine sodium treatment by aerosol, and applying 2 weeks is 1 course for the treatment of, result Showing, after treatment, 31 example patients reach normal, and other 2 example patients are taken a turn for the better, and cure rate is 93.9%, and effective percentage is 100%, After treatment, stable curative effect is held time length.

Claims (1)

1. a cefobutazine sodium aerosol, it includes by weight:
CN201510124363.0A 2015-03-20 2015-03-20 Preparation containing cefobutazine sodium Expired - Fee Related CN104688742B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510124363.0A CN104688742B (en) 2015-03-20 2015-03-20 Preparation containing cefobutazine sodium

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510124363.0A CN104688742B (en) 2015-03-20 2015-03-20 Preparation containing cefobutazine sodium

Publications (2)

Publication Number Publication Date
CN104688742A CN104688742A (en) 2015-06-10
CN104688742B true CN104688742B (en) 2017-01-04

Family

ID=53336569

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510124363.0A Expired - Fee Related CN104688742B (en) 2015-03-20 2015-03-20 Preparation containing cefobutazine sodium

Country Status (1)

Country Link
CN (1) CN104688742B (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104208043A (en) * 2013-05-29 2014-12-17 天津金耀集团有限公司 Inhalation preparation containing cephalosporin antibiotic

Also Published As

Publication number Publication date
CN104688742A (en) 2015-06-10

Similar Documents

Publication Publication Date Title
JP6870029B2 (en) Ceftrozan antibiotic composition
CN106176617B (en) Amoxicillin soluble powder and preparation method thereof
BRPI0612447A2 (en) fixed dose antibiotic composition, process for the preparation of a fixed dose antibiotic combination product, process for the preparation of a liquid injection and uses of dry powder for injection and liquid injection
JP2020193215A (en) Novel compositions and therapeutic methods
CN105434373A (en) Oxiracetam freeze-drying preparation for injection and preparation method thereof
CN102525963B (en) Netilmicin sulfate lyophiled powder injection and preparation method thereof
CN103222978A (en) Compound sulphamethoxazole injection and preparation method thereof
Goudah et al. The disposition of marbofloxacin after single dose intravenous, intramuscular and oral administration to Muscovy ducks.
CN106727578A (en) Compound Sulfachorpyrdazine Sodium Powder and preparation method thereof
Corum et al. Pharmacokinetics of cefquinome after single and repeated subcutaneous administrations in sheep
CN104013629B (en) The compound medicament composition of cefoperazone sodium and tazobactam sodium and preparation technology thereof
CN104688742B (en) Preparation containing cefobutazine sodium
CN108670956A (en) A kind of amoxicillin soluble powder and preparation method thereof
CN102935065A (en) Soluble dosage forms containing cephem derivatives suitable for parenteral administration
CN103330933B (en) Pharmaceutical composition containing MFG or its salt
CN106176722A (en) A kind of imipenem for injection cilastatin sodium aseptic powdery preparation and preparation method thereof
CN111440195B (en) Cefuroxime magnesium compound, composition, preparation method and application
CN102973500A (en) Linezolid liquid preparation and preparation method thereof
CN107375211B (en) Children sublingual spray of tosufloxacin tosylate and preparation method thereof
CN101972257B (en) A kind of pharmaceutical composition containing Moxifloxacin
CN103230367B (en) Cefpodoxime proxetil composition dry suspension and preparation method thereof
CN103655460B (en) Injection medicinal composition containing aztreonam, as well as preparation method and application thereof
CN112569211A (en) Gatifloxacin solution for inhalation and preparation method thereof
Sayed et al. Pharmacokinetics and tissue residues of cephradine in healthy and experimentally Salmonella entretidis infected broiler chickens
BR112015014145B1 (en) antibacterial compounds, pharmaceutical composition, their preparation and combination processes

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C41 Transfer of patent application or patent right or utility model
CB03 Change of inventor or designer information

Inventor after: Niu Jingyuan

Inventor after: Zhang Bin

Inventor after: Wang Shuai

Inventor after: Zhao Shan

Inventor after: Yan Xiaoxiao

Inventor after: Wang Haitao

Inventor before: Liu Ying

COR Change of bibliographic data
TA01 Transfer of patent application right

Effective date of registration: 20160921

Address after: Xinxiang City, Henan province 453003 Jinsui Road No. 601, Xinxiang Medical University

Applicant after: Xinxiang Medical College

Address before: 610000 Sichuan city of Chengdu province high tech Zone Kyrgyzstan Road No. 666 Building 2 floor 13 No. 2

Applicant before: Chengdu Hui Zhi distant view Science and Technology Ltd.

C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20170104

Termination date: 20170320

CF01 Termination of patent right due to non-payment of annual fee